HCIC 2025: Data for smarter healthcare marketing
Our team had a great time at HCIC connecting with healthcare marketers, digital teams and consumer...
Our team had a great time at HCIC connecting with healthcare marketers, digital teams and consumer...
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
The one constant in healthcare marketing is change, particularly in four key areas: Evolving...
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
With the start of 2024, we are moving toward a world without third-party cookies to track consumer...
As therapies become increasingly complex and personalized, it is imperative that physicians...
FDA has made its expectations for RWE clearer and more structured through recent guidance and program activity. For sponsors, that changes the risk profile: evidence that is fast to generate but weak on data quality, provenance and reproducibility is...